WeVote
Log In

Bill

Bill

SD 3291

Massachusetts Bay Transportation Authority Naloxone Pilot Report

194th Legislature (2025-2026)

MBTA must pilot naloxone distribution at transit stations and report feasibility, costs, and recommendations for opioid overdose response in public transit.

Placed on file
0
WeVote Research Nonpartisan
Bill Summary · SD 3291

Legislative bill overview

SD 3291 requires the Massachusetts Bay Transportation Authority (MBTA) to conduct a pilot program studying the distribution and use of naloxone (Narcan) at transit stations and vehicles. The bill mandates a report detailing findings from this pilot initiative, including implementation feasibility, cost-benefit analysis, and recommendations for broader deployment.

Why is this important

Opioid overdoses remain a public health crisis, and transit systems serve vulnerable populations with higher overdose risks. Naloxone availability in public spaces has been shown to save lives by reversing opioid overdoses, and transit authority participation could expand access to this lifesaving medication in locations where people congregate regularly.

Potential points of contention

  • Operational burden and liability: MBTA may resist additional responsibilities, citing concerns about staff training requirements, liability exposure if naloxone is misused, and costs associated with purchasing and maintaining supplies
  • Cost and resource allocation: Questions about funding sources for the pilot and whether transit authority budgets should prioritize this versus core transportation services
  • Implementation logistics: Practical challenges around safe storage, staff accessibility during emergencies, coordination with emergency responders, and ensuring proper training for transit personnel

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.